News Conference News ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions Yael L. Maxwell November 30, 2011
News Conference News TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year L.A. McKeown November 28, 2011
News Conference News PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis November 27, 2011
News Conference News RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis November 22, 2011
News Conference News Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk November 17, 2011
News Conference News ‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year November 16, 2011
News Industry News REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES November 13, 2011
News Conference News ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients November 13, 2011
News Industry News Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions November 10, 2011
News Industry News Polymer-free drug eluting stents result in lower in-stent late loss November 10, 2011
News Industry News Paclitaxel-coated balloon angioplasty demonstrates superior results November 10, 2011
News Industry News Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority November 10, 2011
News Industry News Clinical trial establishes non-inferiority of drug-eluting stent with a bioabsorbable polymer November 10, 2011
News Industry News Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents November 09, 2011
News Industry News Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco November 09, 2011